Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Teixeira

Showing results (121-130 of 134) with videos related to

Pageof 14
Sort By:
Biochimica Et Biophysica Acta|April 12, 2016
Structural and functional evaluation of the palindromic alanine-rich antimicrobial peptide Pa-MAP2Ludovico Migliolo, Mário R Felício, Marlon H Cardoso, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 10, 2016
Efficacy and safety of adalimumab in Chinese patients with moderate-to-severe plaque psoriasis: results from a phase 3, randomized, placebo-controlled, double-blind studyL Cai, J Gu, J Zheng, et al.
Pathogens (Basel, Switzerland)|August 28, 2025
Anti-SARS-CoV-2 Antibodies in Urine of Individuals Vaccinated with Janssen AD26.COV2.S COVID-19 VaccineMarina F N Melo, Rômulo C D Lira, Raquel S B Câmara, et al.
Lancet (London, England)|May 23, 2021
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trialsEmma Guttman-Yassky, Henrique D Teixeira, Eric L Simpson, et al.
JAMA Dermatology|October 23, 2024
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis: Analysis of 3 Phase 3 Randomized Clinical Trials Through 76 WeeksAmy S Paller, Pedro Mendes-Bastos, Elaine Siegfried, et al.
JAMA Dermatology|April 12, 2023
Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical TrialsAmy S Paller, Barry Ladizinski, Pedro Mendes-Bastos, et al.
American Journal of Clinical Dermatology|September 3, 2025
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 WeeksAlan D Irvine, Vimal H Prajapati, Emma Guttman-Yassky, et al.
Scientific Reports|January 13, 2021
Tropical rhodolith beds are a major and belittled reef fish habitatRodrigo L Moura, Maria L Abieri, Guilherme M Castro, et al.
Hypertension (Dallas, Tex. : 1979)|March 23, 2011
Angiotensin II binding to angiotensin I-converting enzyme triggers calcium signalingPaola B Guimarães, Érika C Alvarenga, Paula D Siqueira, et al.
International Journal of Environmental Research and Public Health|December 11, 2022
Development of a Cyclic Voltammetry-Based Method for the Detection of Antigens and Antibodies as a Novel Strategy for Syphilis DiagnosisGabriel M C Barros, Dionísio D A Carvalho, Agnaldo S Cruz, et al.
Pageof 14

Showing results (121-130 of 134) with videos related to

Sort By:
Pageof 14
Biochimica Et Biophysica Acta|April 12, 2016
Structural and functional evaluation of the palindromic alanine-rich antimicrobial peptide Pa-MAP2Ludovico Migliolo, Mário R Felício, Marlon H Cardoso, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|August 10, 2016
Efficacy and safety of adalimumab in Chinese patients with moderate-to-severe plaque psoriasis: results from a phase 3, randomized, placebo-controlled, double-blind studyL Cai, J Gu, J Zheng, et al.
Pathogens (Basel, Switzerland)|August 28, 2025
Anti-SARS-CoV-2 Antibodies in Urine of Individuals Vaccinated with Janssen AD26.COV2.S COVID-19 VaccineMarina F N Melo, Rômulo C D Lira, Raquel S B Câmara, et al.
Lancet (London, England)|May 23, 2021
Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trialsEmma Guttman-Yassky, Henrique D Teixeira, Eric L Simpson, et al.
JAMA Dermatology|October 23, 2024
Upadacitinib in Adolescents With Moderate to Severe Atopic Dermatitis: Analysis of 3 Phase 3 Randomized Clinical Trials Through 76 WeeksAmy S Paller, Pedro Mendes-Bastos, Elaine Siegfried, et al.
JAMA Dermatology|April 12, 2023
Efficacy and Safety of Upadacitinib Treatment in Adolescents With Moderate-to-Severe Atopic Dermatitis: Analysis of the Measure Up 1, Measure Up 2, and AD Up Randomized Clinical TrialsAmy S Paller, Barry Ladizinski, Pedro Mendes-Bastos, et al.
American Journal of Clinical Dermatology|September 3, 2025
Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 WeeksAlan D Irvine, Vimal H Prajapati, Emma Guttman-Yassky, et al.
Scientific Reports|January 13, 2021
Tropical rhodolith beds are a major and belittled reef fish habitatRodrigo L Moura, Maria L Abieri, Guilherme M Castro, et al.
Hypertension (Dallas, Tex. : 1979)|March 23, 2011
Angiotensin II binding to angiotensin I-converting enzyme triggers calcium signalingPaola B Guimarães, Érika C Alvarenga, Paula D Siqueira, et al.
International Journal of Environmental Research and Public Health|December 11, 2022
Development of a Cyclic Voltammetry-Based Method for the Detection of Antigens and Antibodies as a Novel Strategy for Syphilis DiagnosisGabriel M C Barros, Dionísio D A Carvalho, Agnaldo S Cruz, et al.
Pageof 14